Aviceda Therapeutics
Mary Trueblood, CPA, currently serves as Senior Director and Head of Accounting at Aviceda Therapeutics since May 2023. Previous roles include Senior Director of Finance at Magenta Therapeutics from November 2017 to February 2023, and Accounting & Finance Consultant for several companies in 2017. Mary held the position of Controller at Tokai Pharmaceuticals, Inc. from 2011 to May 2017 and has experience as a consultant for bluebirdbio and an Interim Controller at Kuebix. Additionally, Mary worked as Client Services Controller at Charles River CFO from 2004 to 2011, overseeing startup operations for venture-backed life science companies. Earlier experience includes positions as Controller at Alnylam Pharmaceuticals and Client Services Controller at Hurley, Vickers and Associates. Mary holds a BS from the University at Albany and an MS/MBA from Northeastern University.
This person is not in any teams
This person is not in any offices
Aviceda Therapeutics
1 followers
Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.